Brief: Synairgen Plc Provides Update On SNG001

Synairgen

03/03/2022 09:17

March 3 (Reuters) - Synairgen PLC  SYNG.L :
    * SYNAIRGEN PLC - ANNOUNCES AN UPDATE ON SNG001 IN ACTIV-2
PHASE 3
TRIAL FOR COVID-19 AND ON SNG001 ACTIVITY AGAINST DELTA AND
OMICRON VARIANTS.
    * SYNAIRGEN PLC - CONTINUES TO AWAIT PHASE 2 DATA FROM US
NIH
ACTIV-2 TRIAL IN HOME-BASED COVID-19 PARTICIPANTS, EXPECTED BY
MID-YEAR.
    * SYNAIRGEN PLC  - UPDATE ON SNG001

Source text for Eikon:  ID:nRSC4606Da 
Further company coverage:  SYNG.L 

 ((Reuters.Briefs@thomsonreuters.com;))